Screener
Madrigal Pharmaceuticals, Inc. MDGL Business Segments — Facility And Other Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept mdgl:FacilityAndOtherExpenses.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Facility related and other internal expenses(1) | (1,486) | (1,656) | (2,669) | (2,781) |
| Selling, general and administrative: | ||||
| Compensation and benefit-related expenses | (80,321) | (52,504) | (163,926) | (100,865) |
| Stock-based compensation | (28,382) | (19,805) | (54,439) | (35,521) |
| Professional fees and other external expenses | (148,996) | (109,841) | (280,248) | (197,855) |
| Facility related and other internal expenses(1) | (31,676) | (14,708) | (59,283) | (30,493) |
| Other segment (expense) income(2) | (1,631) | 4,921 | (3,299) | 10,994 |
| Net loss | $(57,939) | $(42,281) | $(152,330) | $(115,519) |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s business segments — facility and other expenses?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported business segments — facility and other expenses of $31.68M in Q2 2026.
- What does business segments — facility and other expenses mean?
- This encompasses overhead costs related to physical office space, laboratories, utilities, and general administrative support. It represents the fixed cost base required to maintain operational infrastructure.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s business segments — facility and other expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude